A first-in-class anticancer dual HDAC2/FAK inhibitors bearing hydroxamates/benzamides capped by pyridinyl-1,2,4-triazoles
Muhamad Mustafa, Amer Ali Abd El‐Hafeez, Dalia Abdelhamid, Gajanan D. Katkar, Yaser A. Mostafa, Pradipta Ghosh, Alaa M. Hayallah, Gamal El‐Din A. Abuo‐Rahma
Topics & Concepts
ChemistryHistone deacetylase 2VorinostatFocal adhesionDocking (animal)Protein kinase BStereochemistryHistone deacetylaseBiochemistryApoptosisCancer researchSignal transductionHistoneDNAMedicineBiologyNursingHistone Deacetylase Inhibitors ResearchPeptidase Inhibition and AnalysisProtein Degradation and Inhibitors